10
Participants
Start Date
August 5, 2022
Primary Completion Date
November 15, 2023
Study Completion Date
November 15, 2023
Brexanolone
Enrolled subjects will receive a 60-hour infusion of Brexanolone (BRX) according to FDA approved protocol for administration. A programmable peristaltic infusion pump will be used to ensure accurate delivery.
University of North Carolina, Chapel Hill
Collaborators (1)
Baszucki Brain Research Fund
OTHER
Sage Therapeutics
INDUSTRY
University of North Carolina, Chapel Hill
OTHER